Uitzending van 26 januari 2021

Speaking in Dutch, Marijn discusses the 2021 Access to Medicine Index. In the interview, Marijn touches on the following points:

• The surge of new R&D projects in the wake of COVID-19 while research into other pandemic risks lag

• The pharmaceutical industry's progress on access to medicine, including improving access to essential products 

• Equitable access to COVID-19 vaccines as a key element in controlling the pandemic and the responsibility of pharmaceutical companies to distribute vaccines fairly throughout different parts of the world.

The interview starts at around 28 minutes and is conducted in Dutch. The full interview can be found here.